Andréia Machado Cardoso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andréia Machado Cardoso has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
- Maria Rosa Chitolina Schetinger
Department of Biochemistry and Molecular Biology, Federal University of Santa Maria (UFSM), Santa Maria, Brazil
13 shared publications Vera Maria Morsch
Biochemistry and Molecular Biology Department, CCNE, Federal University of Santa Maria, RS, Brazil
10 shared publications- Margarete Dulce Bagatini
Graduate Program in Medical Sciences, Federal University of Fronteira Sul, Chapecó 89815-899, SC, Brazil
9 shared publications Aline Mânica
Health Sciences Postgraduate Program, Community University of Chapecó Region, Chapecó, SC, Brazil
7 shared publicationsDaniela Zanini
Graduate Program in Biomedical Sciences
6 shared publications- Daniela Zanini
Graduate Program in Biomedical Sciences, Universidade Federal da Fronteira Sul, Curso de Medicina, Chapecó City, Brazil
6 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Elsevier in Journal of Diabetes and its Complications
Beyond weight loss: GLP-1–based therapies and the reversal of type 2 diabetes pathophysiology
- 18 November 2026
- Published by Elsevier in Journal of Diabetes and its Complications
Open AccessBeyond weight loss: GLP-1–based therapies and the reversal of type 2 diabetes pathophysiology
- 30 October 2026
- Published by Wolters Kluwer Health in Journal Of Hypertension
Exercise attenuates hypertension-induced renal dysfunction alongside changes in purine metabolism and A2A and P2X7 receptor expression
Background: Hypertension-induced renal dysfunction is associated with endothelial dysfunction and changes in purinergic signaling. Exercise training can attenuate hypertension-related disturbances in purinergic pathways, but its effects on renal purine metabolism and purinergic receptor expression remain poorly understood. We investigated these responses in L-NAME-induced hypertensive rats. Methods: Male Wistar rats were assigned to Control, Exercise, L-NAME, and Exercise L-NAME groups ( n = 10/group). Hypertension was induced by chronic Nω-nitro- L -arginine methyl ester (L-NAME) administration, and exercise consisted of 6 weeks of swimming training. Blood pressure, renal nitric oxide metabolites (NOx), renal function, serum ATP, renal ATP, ADP, and AMP hydrolysis, ADA activity, and renal expression of purinergic enzymes and P1, P2X, and P2Y receptors were evaluated. Results: L-NAME increased blood pressure, serum ATP, urea, and creatinine and reduced renal NOx concentrations. Hypertensive animals showed increased CD39 and ADA expression, increased ATP hydrolysis and ADA activity, reduced A1 and A2A receptor expression, and increased P2X4 and P2X7 expression. Exercise attenuated serum ATP accumulation, changes in renal purine-metabolizing enzyme activities, and ADA expression; preserved A2A and P2X1 expression; and attenuated increases in P2X4 and P2X7 expression. Significant correlations among serum ATP, creatinine, A2A, and P2X7 expression occurred exclusively in L-NAME-treated animals. Conclusions: L-NAME-induced hypertension is associated with renal dysfunction, changes in renal purine metabolism, and selective changes in purinergic receptor gene expression. Swimming training attenuated several of these responses and improved renal function. These findings identify renal purine metabolism and A2A and P2X7 receptor expression as potential pathways associated with exercise-induced protection that warrant further mechanistic investigation.
- 30 October 2026
- Published by Wolters Kluwer Health in Journal Of Hypertension
Exercise attenuates hypertension-induced renal dysfunction alongside changes in purine metabolism and A2A and P2X7 receptor expression
Background: Hypertension-induced renal dysfunction is associated with endothelial dysfunction and changes in purinergic signaling. Exercise training can attenuate hypertension-related disturbances in purinergic pathways, but its effects on renal purine metabolism and purinergic receptor expression remain poorly understood. We investigated these responses in L-NAME-induced hypertensive rats. Methods: Male Wistar rats were assigned to Control, Exercise, L-NAME, and Exercise L-NAME groups ( n = 10/group). Hypertension was induced by chronic Nω-nitro- L -arginine methyl ester (L-NAME) administration, and exercise consisted of 6 weeks of swimming training. Blood pressure, renal nitric oxide metabolites (NOx), renal function, serum ATP, renal ATP, ADP, and AMP hydrolysis, ADA activity, and renal expression of purinergic enzymes and P1, P2X, and P2Y receptors were evaluated. Results: L-NAME increased blood pressure, serum ATP, urea, and creatinine and reduced renal NOx concentrations. Hypertensive animals showed increased CD39 and ADA expression, increased ATP hydrolysis and ADA activity, reduced A1 and A2A receptor expression, and increased P2X4 and P2X7 expression. Exercise attenuated serum ATP accumulation, changes in renal purine-metabolizing enzyme activities, and ADA expression; preserved A2A and P2X1 expression; and attenuated increases in P2X4 and P2X7 expression. Significant correlations among serum ATP, creatinine, A2A, and P2X7 expression occurred exclusively in L-NAME-treated animals. Conclusions: L-NAME-induced hypertension is associated with renal dysfunction, changes in renal purine metabolism, and selective changes in purinergic receptor gene expression. Swimming training attenuated several of these responses and improved renal function. These findings identify renal purine metabolism and A2A and P2X7 receptor expression as potential pathways associated with exercise-induced protection that warrant further mechanistic investigation.
- Open Access
- 27 October 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
GLP‐1–Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection
Aims: To critically examine the evolving evidence on glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 receptor agonist tirzepatide as adjuncts to insulin therapy in type 1 diabetes (T1D), with particular emphasis on their benefit–risk balance in individuals with overweight or obesity. Materials and Methods: This narrative review examines evidence on liraglutide, semaglutide and tirzepatide in T1D, focusing on effects on body weight and insulin requirements, alongside hypoglycaemia, ketosis, diabetic ketoacidosis and gastrointestinal tolerability. Results: Early trials with liraglutide demonstrated reductions in body weight and insulin requirements but raised concerns regarding hypoglycaemia and ketosis. More recently, semaglutide and tirzepatide have renewed interest in incretin‐based therapy in T1D, particularly among individuals with obesity. Their greater effects on weight and insulin requirements introduce a clinically important safety challenge: insulin must be reduced sufficiently to prevent hypoglycaemia while maintaining adequate insulinization to suppress lipolysis and ketogenesis. Gastrointestinal adverse events may further destabilize this balance through reduced carbohydrate intake and dehydration. Conclusion: Current evidence supports a phenotype‐directed approach centred primarily on adults with T1D and obesity, accompanied by careful patient selection, individualised insulin adjustment, glucose and ketone monitoring, and structured patient education. The clinical question has shifted from whether GLP‐1–based therapies are effective in T1D to which patients are most likely to achieve a favourable benefit–risk balance and how these therapies can be used safely.
- 27 October 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Open AccessGLP‐1–Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection
Aims: To critically examine the evolving evidence on glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 receptor agonist tirzepatide as adjuncts to insulin therapy in type 1 diabetes (T1D), with particular emphasis on their benefit–risk balance in individuals with overweight or obesity. Materials and Methods: This narrative review examines evidence on liraglutide, semaglutide and tirzepatide in T1D, focusing on effects on body weight and insulin requirements, alongside hypoglycaemia, ketosis, diabetic ketoacidosis and gastrointestinal tolerability. Results: Early trials with liraglutide demonstrated reductions in body weight and insulin requirements but raised concerns regarding hypoglycaemia and ketosis. More recently, semaglutide and tirzepatide have renewed interest in incretin‐based therapy in T1D, particularly among individuals with obesity. Their greater effects on weight and insulin requirements introduce a clinically important safety challenge: insulin must be reduced sufficiently to prevent hypoglycaemia while maintaining adequate insulinization to suppress lipolysis and ketogenesis. Gastrointestinal adverse events may further destabilize this balance through reduced carbohydrate intake and dehydration. Conclusion: Current evidence supports a phenotype‐directed approach centred primarily on adults with T1D and obesity, accompanied by careful patient selection, individualised insulin adjustment, glucose and ketone monitoring, and structured patient education. The clinical question has shifted from whether GLP‐1–based therapies are effective in T1D to which patients are most likely to achieve a favourable benefit–risk balance and how these therapies can be used safely.
- Open Access
- 17 March 2026
- Published by Springer Nature in Purinergic Signalling
- Vol. 22 (2) , 28
Mixed circuit training as a non-pharmacological strategy to improve platelet function and oxidative balance in type 2 diabetes: role of purinergic signaling
This study investigates the impact of a 16-week mixed circuit training (MCT) program on purinergic signaling and oxidative stress markers in women with type 2 diabetes mellitus (T2DM), focusing on its potential to modulate platelet-related purinergic signaling and oxidative stress markers that are mechanistically linked to platelet activation. A total of 21 women with T2DM and 23 non-diabetic controls, all sedentary and middle-aged, underwent MCT twice weekly. Biochemical, hemodynamic, and oxidative stress parameters, along with platelet ectonucleotidase activity and extracellular ATP levels, were assessed pre- and post-intervention. MCT significantly decreased ectonucleotidase diphosphohydrolase (E-NTPDase) activity for ADP hydrolysis in platelets, along with a reduction in extracellular ATP levels, indicating a modulation of purinergic signaling. Additionally, exercise enhanced antioxidant defenses, increasing glutathione-S-transferase (GST) activity and vitamin C levels, while reducing myeloperoxidase (MPO) activity, a key pro-oxidant enzyme. These changes suggest a shift toward a biochemical profile that may be relevant to thromboinflammatory pathways; however, no direct measures of platelet aggregation were performed. Mixed circuit training emerges as a valuable non-pharmacological strategy for improving oxidative balance and modulating purinergic markers in women with T2DM, warranting future studies including functional platelet assays and clinical outcomes.
- 17 March 2026
- Published by Springer Nature in Purinergic Signalling
- Vol. 22 (2) , 28
Open AccessMixed circuit training as a non-pharmacological strategy to improve platelet function and oxidative balance in type 2 diabetes: role of purinergic signaling
This study investigates the impact of a 16-week mixed circuit training (MCT) program on purinergic signaling and oxidative stress markers in women with type 2 diabetes mellitus (T2DM), focusing on its potential to modulate platelet-related purinergic signaling and oxidative stress markers that are mechanistically linked to platelet activation. A total of 21 women with T2DM and 23 non-diabetic controls, all sedentary and middle-aged, underwent MCT twice weekly. Biochemical, hemodynamic, and oxidative stress parameters, along with platelet ectonucleotidase activity and extracellular ATP levels, were assessed pre- and post-intervention. MCT significantly decreased ectonucleotidase diphosphohydrolase (E-NTPDase) activity for ADP hydrolysis in platelets, along with a reduction in extracellular ATP levels, indicating a modulation of purinergic signaling. Additionally, exercise enhanced antioxidant defenses, increasing glutathione-S-transferase (GST) activity and vitamin C levels, while reducing myeloperoxidase (MPO) activity, a key pro-oxidant enzyme. These changes suggest a shift toward a biochemical profile that may be relevant to thromboinflammatory pathways; however, no direct measures of platelet aggregation were performed. Mixed circuit training emerges as a valuable non-pharmacological strategy for improving oxidative balance and modulating purinergic markers in women with T2DM, warranting future studies including functional platelet assays and clinical outcomes.
- Open Access
- 2 January 2026
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 26 (51) , e16418
Motivações de mulheres pelo parto domiciliar planejado após parto vaginal hospitalar
Objetivo: analisar as experiências que motivaram a escolha de mulheres pelo parto domiciliar planejado após parto vaginal hospitalar. Método: trata-se de um estudo de abordagem qualitativa, do tipo descritivo e exploratório, realizado no oeste catarinense, sul do Brasil, com mulheres que tiveram parto domiciliar planejado após parto vaginal hospitalar anterior. Os dados foram coletados de setembro a dezembro de 2022, de forma triangulada, por meio de entrevistas semiestruturadas, informações recolhidas das cadernetas de gestantes e das fichas de registros das equipes que atenderam aos partos. Foi utilizada análise de conteúdo temática, culminando no tema “Experiências hospitalares prévias”. Resultados: participaram do estudo 11 mulheres que relataram experiências hospitalares prévias negativas, incluindo diversas formas de violência obstétrica e neonatal como principais motivações para a escolha pelo parto domiciliar. Os relatos revelaram traumas e insatisfações com a assistência hospitalar, destacando intervenções desnecessárias, falta de privacidade e desrespeito às preferências pessoais durante o período parturitivo e no pós-parto, o que levou as mulheres a desejarem um ambiente mais respeitoso e personalizado nas gestações seguintes. Conclusão: a escolha pelo parto domiciliar planejado reflete a busca das mulheres por maior autonomia e segurança no processo parturitivo, com uma assistência que preza pelo respeito, centrada na qualidade do atendimento prestado ao binômio mãe e bebê. Destaca-se a necessidade de revisão das práticas hospitalares e promoção de acompanhamento humanizado que valorize o protagonismo e a fisiologia da parturiente.
- 2 January 2026
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 26 (51) , e16418
Open AccessMotivações de mulheres pelo parto domiciliar planejado após parto vaginal hospitalar
Objetivo: analisar as experiências que motivaram a escolha de mulheres pelo parto domiciliar planejado após parto vaginal hospitalar. Método: trata-se de um estudo de abordagem qualitativa, do tipo descritivo e exploratório, realizado no oeste catarinense, sul do Brasil, com mulheres que tiveram parto domiciliar planejado após parto vaginal hospitalar anterior. Os dados foram coletados de setembro a dezembro de 2022, de forma triangulada, por meio de entrevistas semiestruturadas, informações recolhidas das cadernetas de gestantes e das fichas de registros das equipes que atenderam aos partos. Foi utilizada análise de conteúdo temática, culminando no tema “Experiências hospitalares prévias”. Resultados: participaram do estudo 11 mulheres que relataram experiências hospitalares prévias negativas, incluindo diversas formas de violência obstétrica e neonatal como principais motivações para a escolha pelo parto domiciliar. Os relatos revelaram traumas e insatisfações com a assistência hospitalar, destacando intervenções desnecessárias, falta de privacidade e desrespeito às preferências pessoais durante o período parturitivo e no pós-parto, o que levou as mulheres a desejarem um ambiente mais respeitoso e personalizado nas gestações seguintes. Conclusão: a escolha pelo parto domiciliar planejado reflete a busca das mulheres por maior autonomia e segurança no processo parturitivo, com uma assistência que preza pelo respeito, centrada na qualidade do atendimento prestado ao binômio mãe e bebê. Destaca-se a necessidade de revisão das práticas hospitalares e promoção de acompanhamento humanizado que valorize o protagonismo e a fisiologia da parturiente.
- 11 August 2025
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (5) , 1115-1133
Adenosine receptors and acute kidney injury: perspectives for future therapy
Adenosine is a key modulator in the pathophysiology of acute kidney injury (AKI), particularly through its influence on inflammatory pathways and renal hemodynamics. This nucleoside exerts its effects via four G protein-coupled receptors-A1, A2A, A2B, and A3-each displaying distinct roles during renal injury. The A1 receptor primarily protects renal tissue under ischemic conditions by reducing metabolic demand, while the A2A receptor promotes anti-inflammatory and vasodilatory effects, improving renal perfusion and attenuating leukocyte infiltration. The A2B receptor, upregulated under hypoxic or injury conditions, is involved in anti-inflammatory actions and vascular integrity, especially in renal tubular and endothelial cells. Conversely, activation of the A3 receptor is generally linked to adverse outcomes, including increased apoptosis and greater tissue damage. Therapeutic strategies targeting adenosine receptors are being actively explored: selective A1 and A2A agonists show potential for promoting renal recovery, while A3 antagonists helped counteract the harmful effects of A3 activation. The review also discusses advances from recent studies (2022-2024), including insights on COVID-19-associated AKI and the nuanced roles of A1 and A3 receptors in different pathological contexts. Additionally, the therapeutic promise of inhibiting adenosine-degrading enzymes, such as ADA and adenosine kinase (ADK), is highlighted. Novel mechanistic insights and recent literature are integrated, providing a comprehensive overview that expands upon previous reviews. Although adenosine receptor modulation holds significant promise as a therapeutic strategy for AKI, further clinical research is necessary to validate efficacy and safety in human populations.
- 11 August 2025
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (5) , 1115-1133
Adenosine receptors and acute kidney injury: perspectives for future therapy
Adenosine is a key modulator in the pathophysiology of acute kidney injury (AKI), particularly through its influence on inflammatory pathways and renal hemodynamics. This nucleoside exerts its effects via four G protein-coupled receptors-A1, A2A, A2B, and A3-each displaying distinct roles during renal injury. The A1 receptor primarily protects renal tissue under ischemic conditions by reducing metabolic demand, while the A2A receptor promotes anti-inflammatory and vasodilatory effects, improving renal perfusion and attenuating leukocyte infiltration. The A2B receptor, upregulated under hypoxic or injury conditions, is involved in anti-inflammatory actions and vascular integrity, especially in renal tubular and endothelial cells. Conversely, activation of the A3 receptor is generally linked to adverse outcomes, including increased apoptosis and greater tissue damage. Therapeutic strategies targeting adenosine receptors are being actively explored: selective A1 and A2A agonists show potential for promoting renal recovery, while A3 antagonists helped counteract the harmful effects of A3 activation. The review also discusses advances from recent studies (2022-2024), including insights on COVID-19-associated AKI and the nuanced roles of A1 and A3 receptors in different pathological contexts. Additionally, the therapeutic promise of inhibiting adenosine-degrading enzymes, such as ADA and adenosine kinase (ADK), is highlighted. Novel mechanistic insights and recent literature are integrated, providing a comprehensive overview that expands upon previous reviews. Although adenosine receptor modulation holds significant promise as a therapeutic strategy for AKI, further clinical research is necessary to validate efficacy and safety in human populations.
- 17 July 2025
- Published by Elsevier in Cellular Signalling
- Vol. 135, 112006
The role of physical exercise on inflammatory profile in chronic renal disease: An overview of the current literature
- 17 July 2025
- Published by Elsevier in Cellular Signalling
- Vol. 135, 112006
The role of physical exercise on inflammatory profile in chronic renal disease: An overview of the current literature
- 16 April 2025
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (5) , 1201-1213
The anti-inflammatory effect of physical exercise on type 2 diabetes: the role of purinergic signaling
This study investigated the effects of physical exercise (PE) on the modulation of purinergic signaling and inflammatory profiles in sedentary women with type 2 diabetes mellitus (T2DM). Over 16 weeks, participants underwent a combined aerobic and resistance training program. The intervention resulted in reduced extracellular ATP levels and decreased activity of E-NTPDase and ADA enzymes, shifting the inflammatory balance toward an anti-inflammatory profile. A significant increase in anti-inflammatory cytokines (IL-10, IL-4) and a decrease in pro-inflammatory markers (TNF-α, IFN-γ, IL-6) were observed in the T2DM group. Correlations indicated that ATP hydrolysis was inversely related to anti-inflammatory cytokines, supporting the role of PE in modulating purinergic pathways. Additionally, improvements in glycemic control, systolic blood pressure, and functional capacity highlighted the systemic benefits of exercise. These findings emphasize the therapeutic potential of PE in managing T2DM by targeting inflammation and metabolic dysregulation through purinergic modulation. Further studies should explore these mechanisms to optimize exercise-based interventions.
- 16 April 2025
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (5) , 1201-1213
The anti-inflammatory effect of physical exercise on type 2 diabetes: the role of purinergic signaling
This study investigated the effects of physical exercise (PE) on the modulation of purinergic signaling and inflammatory profiles in sedentary women with type 2 diabetes mellitus (T2DM). Over 16 weeks, participants underwent a combined aerobic and resistance training program. The intervention resulted in reduced extracellular ATP levels and decreased activity of E-NTPDase and ADA enzymes, shifting the inflammatory balance toward an anti-inflammatory profile. A significant increase in anti-inflammatory cytokines (IL-10, IL-4) and a decrease in pro-inflammatory markers (TNF-α, IFN-γ, IL-6) were observed in the T2DM group. Correlations indicated that ATP hydrolysis was inversely related to anti-inflammatory cytokines, supporting the role of PE in modulating purinergic pathways. Additionally, improvements in glycemic control, systolic blood pressure, and functional capacity highlighted the systemic benefits of exercise. These findings emphasize the therapeutic potential of PE in managing T2DM by targeting inflammation and metabolic dysregulation through purinergic modulation. Further studies should explore these mechanisms to optimize exercise-based interventions.
- 25 February 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 209, 104675
Relationship between purinergic signalling and oxidative stress in prostate cancer: Perspectives for future therapy
- 25 February 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 209, 104675
Relationship between purinergic signalling and oxidative stress in prostate cancer: Perspectives for future therapy
- 16 May 2024
- Published by Springer Nature in Purinergic Signalling
- Vol. 20 (6) , 607-616
Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets
Cervical cancer ranks as the fourth most common and fatal cancer among women worldwide. Studies have demonstrated a strong association between purinergic platelet signaling and tumor progression in this type of cancer. The literature shows that neoplastic cells, when in the bloodstream, secrete adenosine triphosphate (ATP) and adenosine nucleotide diphosphate (ADP) that act on their corresponding platelet P2Y and P2X receptors. The interaction of these nucleotides with their receptors results in platelet activation and degranulation, ensuing several consequences, such as vascular endothelial growth factor (VEGF), platelet-derived growth factor, matrix metalloproteinases, ADP, and ATP. These molecules play essential roles in angiogenesis and tumor metastasis in cervical cancer. Several purinergic receptors are found in endothelial cells. Their activation, especially P2Y2, by the nucleotides released by platelets can induce relaxation of the endothelial barrier and consequent extravasation of tumor cells, promoting the development of metastases. Cancer cells that enter the bloodstream during the metastatic process are also subject to high shear stress and immune surveillance. In this context, activated platelets bind to circulating tumor cells and protect them against shear stress and the host’s immune system, especially against natural killer cells, facilitating their spread throughout the body. Furthermore, activation of the P2Y12 receptor present on the platelet surface promotes the release of VEGF, the main inducer of angiogenesis in cervical cancer, in addition to increasing the concentration of several other pro-angiogenic molecules. Therefore, this review will address the role of platelet purinergic signaling in tumor progression of cervical cancer and propose possible therapeutic targets. Graphical Abstract
- 16 May 2024
- Published by Springer Nature in Purinergic Signalling
- Vol. 20 (6) , 607-616
Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets
Cervical cancer ranks as the fourth most common and fatal cancer among women worldwide. Studies have demonstrated a strong association between purinergic platelet signaling and tumor progression in this type of cancer. The literature shows that neoplastic cells, when in the bloodstream, secrete adenosine triphosphate (ATP) and adenosine nucleotide diphosphate (ADP) that act on their corresponding platelet P2Y and P2X receptors. The interaction of these nucleotides with their receptors results in platelet activation and degranulation, ensuing several consequences, such as vascular endothelial growth factor (VEGF), platelet-derived growth factor, matrix metalloproteinases, ADP, and ATP. These molecules play essential roles in angiogenesis and tumor metastasis in cervical cancer. Several purinergic receptors are found in endothelial cells. Their activation, especially P2Y2, by the nucleotides released by platelets can induce relaxation of the endothelial barrier and consequent extravasation of tumor cells, promoting the development of metastases. Cancer cells that enter the bloodstream during the metastatic process are also subject to high shear stress and immune surveillance. In this context, activated platelets bind to circulating tumor cells and protect them against shear stress and the host’s immune system, especially against natural killer cells, facilitating their spread throughout the body. Furthermore, activation of the P2Y12 receptor present on the platelet surface promotes the release of VEGF, the main inducer of angiogenesis in cervical cancer, in addition to increasing the concentration of several other pro-angiogenic molecules. Therefore, this review will address the role of platelet purinergic signaling in tumor progression of cervical cancer and propose possible therapeutic targets. Graphical Abstract